The frequency of gastric Crohn's disease has been considered low. This study was undertaken to determine the prevalence of chronic gastritis and Helicobacter pylori infection in patients with Crohn's disease. Oesophagogastroduodenoscopy was performed on 62 consecutive patients suffering from ileocolonic Crohn's disease. Biopsy specimens from the antrum and corpus were processed for both histological and bacteriological examinations. Hpylori antibodies of IgG and IgA classes were measured in serum samples by enzyme immunoassay. Six patients (9.70/o) were infected with H pylorn, as shown by histology, and in five of them the infection was also verified by serology. Twenty one patients (32%) had chronic H pyloni negative gastritis (negative by both histology and serology) and one of them also had atrophy in the antrum and corpus. Granulomas were found in four patients.
The frequency of gastroduodenal Crohn's disease (CD) has been reported as 2-4% in patients with disease affecting the lower gastrointestinal tract.' 2 Recent reports indicate, however, that the frequency is higher, even more than 30%, especially in children and adolescents.3 4 Sarcoid granulomas, diagnostic for CD, are common in children and in patients with a short history of the disease. If granulomas are absent, gastroduodenal CD is diagnosed by combining the clinical, radiological, endoscopic, and histological findings.3 5 More than 90% of patients with duodenal ulcers have gastritis associated with Helicobacter pylori infection.6 7 Recent reports have suggested that CD can be one of the main causes of H pylori negative duodenal ulcers.8 9 In a previous study we described upper gastrointestinal lesions characteristic of CD in 17% of patients with ileocolonic manifestations of the disease.10 Furthermore, 40% of these patients had chronic, non-specific gastritis. This study aimed to determine the prevalence of chronic gastritis and that of H pylori infection in patients with CD who had undergone oesophagogastroduodenoscopy (OGDS) at (Fig 1) . In a third of these patients the inflammation was graded as moderate or severe, and in these seven patients especially, the inflammatory changes in the gastric mucosa resembled those seen in the acute involvement of the gut in Crohn's disease. The patients with H pylon negative gastritis had a significantly more active disease in the gut than those with normal gastric mucosa (p<0.01, Table II ). Four of the 62 patients showed microgranulomas in the gastric mucosa. One patient with H pylori positive atrophic gastritis and a deep ulceration and an incipient stenosis in the upper cardia had a microgranuloma at the edge and cephalosporin or metronidazole and aminoglycoside. There was no association between gastrointestinal surgery and the presence or absence of Hpylori infection (Table III) . Medical treatments for Crohn's disease before the endoscopy are shown in Table III . Thirty eight patients had not received any medical treatment in the three months immediately before the endoscopy, but some had had antimicrobial prophylaxis or antimicrobial therapy of short duration earlier in connection with bowel surgery (Table III) . There were no significant differences, however, in any medical treatment in the patients with gastritis or normal mucosa or in those with or without H pylori infection (Table III) .
No use of non-steroidal anti-inflammatory drugs or heavy alcohol consumption were reported. Fourteen of the patients were smokers but only three of these had H pylori negative gastritis.
Discussion
The frequency of gastric CD has previously been considered to be low.2 5 This might have been due to difficulties in diagnosing typical radiological or endoscopic findings, such as strictures, aphtous or longitudinal ulcerations or cobble stone, as well as granulomas in histological specimens which are required for the diagnosis. Furthermore, it has been difficult to differentiate the inflammatory lesions seen in CD from other gastroduodenal diseases, particularly the peptic ulcer disease and ordinary H pylori positive gastritis. In the present study, gastric microgranulomas were detected only in four (6.5%) of the 62 patients. However, a third of the patients showed chronic H pylori negative gastritis, the inflammatory changes of which resembled those seen in the active CD in the gut. Thus, it seems that gastric involvement of CD is not as rare as previously thought.
Most examination of Giemsa stained gastric biopsy specimens. The colonisation of Hpylori can be patchy on the gastric mucosa and therefore the prevalence of H pylori in the present patients was confirmed by the determination of Hpylori antibodies in the serum samples. All except one of the patients with histologically proved H pylori infection showed raised antibodies against H pylori. No further H pylori positive patients were found by serology. Thus, the prevalence of Hpylori infection in CD seems to be low. In a recent report by El-Omar et al the prevalence of H pylori infection was low in patients with an inflammatory bowel disease, including both the patients with ulcerative colitis and those with CD.18 It was suggested that this might have been due to the eradication of H pylorn infection in patients with long term treatment with sulphasalazine. In the present study, 10 patients had been treated with long term sulphasalazine (Table III) , and two of these patients were still H pylori positive. In addition, as other antimicrobial treatments of long or short duration were considered, no significant differences were found between patients with gastritis or normal mucosa and between patients with or without H pylori infection (Table III) . Although the medical treatments given to these patients would, by some mechanism, have led to the eradication of H pylorn, the histological findings of focal inflammation can hardly be explained as sequelae of the eradication of Hpyloni.
Our results support an earlier assumption that CD is a generalised inflammatory disease of the whole gastrointestinal tract. Before the era of H pylori, focal gastric inflammatory changes similar to the present findings were described on the gastric mucosa of patients with CD by Korelitz et al19 and SchmitzMoormann et al. 4 However, in those reports the diagnosis of gastric CD was confirmed by concomitant findings of granulomas and other findings characteristic of CD. As the patients with H pylori negative gastritis had active disease in the gut significantly more often than those with normal gastric mucosa, we suggest that gastric manifestations could be used as markers of an exacerbation of CD in the gut. A prospective study in which endoscopical biopsy specimens are taken during active and inactive periods of CD from H pylori negative patients might give further information on the gastritis associated with this disease.
We conclude that the prevalence of the ordinary H pylori positive gastritis is low in patients with CD, but that CD associated Hpylori negative gastritis is relatively common. The diagnosis of this 'Crohn's gastritis' requires careful interpretation of endoscopic and histological findings and it has to be based on exclusion of other gastric diseases. In the present study gastric involvement of CD was shown to be more common than previously thought and associated with more severe diseases in the gut. 
